Atlas Trials

Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases

Clinical trial NCT02967380 · TERMINATED

Trial details

NCT number
NCT02967380
Sponsor
University of Southern California
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
Adult Anaplastic (Malignant) MeningiomaAdult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic OligodendrogliomaAdult Brain Stem GliomaAdult Choroid Plexus NeoplasmAdult Diffuse AstrocytomaAdult EpendymoblastomaAdult EpendymomaAdult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma
Start date
2011-12-14
Primary completion
2014-10-14
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.